Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ · Healthcare
Regeneron Pharmaceuticals, Inc. Income Statement 2008–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||||
| Revenue | 14.34B | 14.20B | 13.12B | 12.17B | 16.07B | 8.50B | 6.56B | 5.15B | 5.87B | 4.86B | 4.10B | 2.82B | 2.10B | 1.38B | 445.8M | 459.1M | 379.3M | 238.5M |
| Gross Profit | — | — | — | — | — | — | 6.15B | 4.91B | 5.67B | 4.67B | 3.86B | 2.69B | 1.99B | 1.29B | 441.6M | 457.0M | 377.6M | 237.5M |
| Profitability | ||||||||||||||||||
| Operating Income | 3.58B | 3.99B | 4.05B | 4.74B | 8.95B | 3.58B | 2.21B | 2.53B | 2.08B | 1.33B | 1.25B | 823.9M | 743.0M | 457.7M | -205.2M | -97.5M | -74.1M | -86.2M |
| EBITDA | 4.12B | 4.47B | 4.47B | 5.08B | 9.23B | 3.81B | 2.42B | 2.68B | 2.23B | 1.44B | 1.33B | 876.6M | 784.3M | 494.7M | -174.1M | -77.8M | -59.9M | -75.0M |
| Net Income | 4.50B | 4.41B | 3.95B | 4.34B | 8.08B | 3.51B | 2.12B | 2.44B | 1.20B | 895.5M | 636.1M | 338.1M | 413.7M | 750.3M | -221.8M | -104.5M | -67.8M | -79.1M |
| Per Share Data | ||||||||||||||||||
| EPS (diluted) | $41.48 | $38.34 | $34.77 | $38.22 | $71.97 | $30.52 | $18.46 | $21.29 | $10.34 | $7.70 | $5.52 | $2.98 | $3.72 | $6.75 | $-2.45 | $-1.26 | — | — |
| Shares Outstanding (dil.) | 109M | 115M | 114M | 114M | 112M | 115M | 115M | 115M | 116M | 116M | 115M | 113M | 111M | 115M | 91M | 83M | 79M | — |
Regeneron Pharmaceuticals Inc. Income Statement — FAQ
Regeneron Pharmaceuticals Inc. (REGN) income statement over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see REGN's income statement history?
The chart and table above show Regeneron Pharmaceuticals Inc.'s income statement by year and by quarter, including the growth rate.